Karo Pharma (Sweden)

Recent papers from Karo Pharma (Sweden)

1. Editorial Expression of Concern: Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivoOncogenesis · 2026
2. Effect of cropping, harvesting, and storage conditions on black spots caused by Rhexocercosporidium carotae: almost two decades of research on the epidemiology of the major disease in Swedish cold-stored carrotsEuropean Journal of Plant Pathology · 2026
3. Harbor Seals ( Phoca vitulina ) Sighted 34 Years After Their Inclusion in a Capture‐Mark‐Recapture StudyMarine Mammal Science · 2025
4. Distribution of plant pathogenic Aphanomyces species in Sweden, Denmark and Lithuania and its relationship with soil factorsJournal of Plant Pathology · 2025
5. Macrocyclic Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse AgonistsACS Medicinal Chemistry Letters · 2023
6. Discovery of 3-Cyano- N -(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H -pyrrolo[2,3- b ]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse AgonistJournal of Medicinal Chemistry · 2018
7. Role of the Bile Acid Transporter SLC10A1 in Liver Targeting of the Lipid-Lowering Thyroid Hormone Analog EprotiromeEndocrinology · 2017
8. An expert system model for mapping tropical wetlands and peatlands reveals South America as the largest contributorGlobal Change Biology · 2017
9. SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cellsOncotarget · 2016
10. Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicityMolecular Cancer · 2014
11. Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humansJournal of Lipid Research · 2014
12. Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver‐selective thyroid hormone receptor agonist eprotiromeJournal of Internal Medicine · 2014
13. The Thyroid Receptor Modulator KB3495 Reduces Atherosclerosis Independently of Total Cholesterol in the Circulation in ApoE Deficient MicePLoS ONE · 2013
14. Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivoOncogenesis · 2013
15. Estrogen Receptors: Therapies Targeted to Receptor SubtypesClinical Pharmacology & Therapeutics · 2010
16. Nitrate-Nitrite-Nitric Oxide PathwayAnesthesiology · 2010
17. Identification of Phenylsulfone-Substituted Quinoxaline (WYE-672) as a Tissue Selective Liver X-receptor (LXR) AgonistJournal of Medicinal Chemistry · 2010
18. Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated DyslipidemiaNew England Journal of Medicine · 2010
19. Indazole-Based Liver X Receptor (LXR) Modulators with Maintained Atherosclerotic Lesion Reduction Activity but Diminished Stimulation of Hepatic Triglyceride SynthesisJournal of Medicinal Chemistry · 2008
20. New scaffolds for the design of selective estrogen receptor modulatorsOrganic & Biomolecular Chemistry · 2008